	Activos Circulantes		Fecha
Acadia Pharmaceuticals	USD 1.06B	14.31M	2025-12
Alaunos Therapeutics	USD 2.68M	1.05M	2025-09
ANI Pharmaceuticals	USD 753.12M	54.72M	2025-12
Ardelyx	USD 367.98M	16.42M	2025-09
Assertio Holdings	USD 263.57M	53.36M	2025-09
Aurora Cannabis	CAD 423.84M	41.46M	2025-09
BioMarin Pharmaceutical	USD 3.95B	98.95M	2025-12
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Canopy Growth	CAD 445.82M	142.46M	2025-09
Corcept Therapeutics	USD 485.46M	55.67M	2025-12
Eli Lilly	USD 55.63B	6.44B	2025-12
Esperion Therapeutics	USD 360.46M	17.87M	2025-09
J&J	USD 55.62B	1.01B	2025-12
Knight Therapeutics	CAD 397.57M	36.96M	2024-09
Lexicon Pharmaceuticals	USD 145.08M	100.72M	2025-06
Merck	USD 47.56B	10.49B	2025-09
Nektar Therapeutics	USD 281.36M	94.79M	2025-09
Novartis	USD 28.2B	2.26B	2025-09
Novartis	USD 28.2B	2.26B	2025-09
Omeros	USD 69.65M	26.53M	2025-06
Pacira	USD 547.97M	14.78M	2025-12
Pfizer	USD 46.92B	3.22B	2025-09
Supernus Pharmaceuticals	USD 644.18M	50.29M	2025-12
TG Therapeutics	USD 630.76M	31M	2025-12

Corcept Therapeutics Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.